Senkus E, Delaloge S, Domchek SM, Conte P, et al. Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: subgroup analyses from the phase III OlympiAD trial. Int J Cancer 2023 Mar 27. doi: 10.1002/ijc.34525.
PMID: 36971103